Josephine Mason

Most people would get COVID-19 vaccine if offered by government or employer: poll

20 Oct 2020

LONDON Most people would get a COVID-19 vaccine if their government or employer recommended it, results of a global poll showed on Tuesday, amid growing concerns about public distrust of the shots being developed at speed to end the pandemic.

Oxford to study anti-inflammatory drug Humira as potential COVID-19 treatment

30 Sep 2020

LONDON Oxford University said on Wednesday it would study whether the world's best-selling prescription medicine, adalimumab, was an effective treatment for COVID-19 patients - the latest effort to repurpose existing drugs as potential coronavirus therapies.

Britain lines up more potential COVID-19 vaccine supplies with J&J, Novavax deals

14 Aug 2020

LONDON Britain will buy potential COVID-19 vaccines from U.S. drugmakers Johnson & Johnson and Novavax Inc , the companies said on Friday, boosting the number of deals it has with drugmakers as the global vaccine race rages on.

It's not for me: speed of COVID-19 vaccine race raises safety concerns

06 Aug 2020

BRUSSELS/LONDON The frenetic race to develop a COVID-19 vaccine has intensified safety concerns about an inoculation, prompting governments and drugmakers to raise awareness to ensure their efforts to beat the coronavirus aren't derailed by public distrust.

WHO sees first results from COVID drug trials within two weeks

03 Jul 2020

GENEVA/LONDON The World Health Organization (WHO) should soon get results from clinical trials it is conducting of drugs that might be effective in treating COVID-19 patients, its Director General Tedros Adhanom Ghebreyesus said on Friday.

UK emergency remdesivir supplies adequate to treat COVID-19, official says

01 Jul 2020

LONDON Britain has adequate supplies of Gilead's remdesivir for emergency use to treat hospitalised COVID-19 patients, England's deputy chief medical officer said on Wednesday, though he warned of potential difficulties securing future supplies.

World News